• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Lixte Biotechnology Holdings, Inc. - Common Stock (NQ:LIXT)

    3.160 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.160
    Bid (Size) 2.950 (200)
    Ask (Size) 3.600 (500)
    Prev. Close 3.160
    Today's Range 3.160 - 3.160
    52wk Range 0.6400 - 6.260
    Shares Outstanding 5,704,200
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit at Morehouse College
    Via Investor Brand Network
    Topics Intellectual Property
    InvestorNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) to Participate In DealFlow Discovery Conference
    Via Investor Brand Network
    Topics Intellectual Property

    Performance

    YTD
    -17.7%
    -17.7%
    1 Month
    -24.2%
    -24.2%
    3 Month
    -26.2%
    -26.2%
    6 Month
    -23.9%
    -23.9%
    1 Year
    +32.6%
    +32.6%

    More News

    Read More
    TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Engages IBN to Support Corporate Communications Strategy
    Via Investor Brand Network
    Topics Intellectual Property
    BioMedNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK
    Via Investor Brand Network
    Topics Intellectual Property
    LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Intellectual Property
    BioMedNewsBreaks — Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Announces $4.3 Million Registered Direct Offering Priced at Market
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
    From Spartan Capital Securities, LLC
    Via GlobeNewswire
    News headline image
    LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities
    Via ACCESS Newswire
    News headline image
    LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology
    Via ACCESS Newswire
    News headline image
    LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)
    Via ACCESS Newswire
    News headline image
    LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)
    Via ACCESS Newswire
    News headline image
    24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor
    Via Newsfile
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Lixte Biotechnology Holdings, Inc. - Common Stock publicly traded?
    Yes, Lixte Biotechnology Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Lixte Biotechnology Holdings, Inc. - Common Stock trade on?
    Lixte Biotechnology Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Lixte Biotechnology Holdings, Inc. - Common Stock?
    The ticker symbol for Lixte Biotechnology Holdings, Inc. - Common Stock is LIXT on the Nasdaq Stock Market
    What is the current price of Lixte Biotechnology Holdings, Inc. - Common Stock?
    The current price of Lixte Biotechnology Holdings, Inc. - Common Stock is 3.160
    When was Lixte Biotechnology Holdings, Inc. - Common Stock last traded?
    The last trade of Lixte Biotechnology Holdings, Inc. - Common Stock was at 01/21/26 04:00 PM ET
    What is the market capitalization of Lixte Biotechnology Holdings, Inc. - Common Stock?
    The market capitalization of Lixte Biotechnology Holdings, Inc. - Common Stock is 18.03M
    How many shares of Lixte Biotechnology Holdings, Inc. - Common Stock are outstanding?
    Lixte Biotechnology Holdings, Inc. - Common Stock has 18M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.